Name	Value
Compound	AZD1480
Investigated event	Influence on protein activity
Experiment type	Western Blot
Concentration	1.00 µM
Cell line	PALNTB (xenograft)
Organism
Animal model
STAT protein
Other	AKT

Evaluation of the in vitro and in vivo efficacy of the JAK inhibitor AZD1480 against JAK-mutated acute lymphoblastic leukemia. Molecular cancer therapeutics Santi Suryani, Lauryn S Bracken, Richard C Harvey, Keith C S Sia, Hernan Carol, I-Ming Chen, Kathryn Evans, Philipp A Dietrich, Kathryn G Roberts, Raushan T Kurmasheva, Catherine A Billups, Charles G Mullighan, Cheryl L Willman, Mignon L Loh, Stephen P Hunger, Peter J Houghton, Malcolm A Smith, Richard B Lock, 14, 2, None, 2014-12-10, 10.1158/1535-7163.MCT-14-0647 DOI: 10.1158/1535-7163.MCT-14-0647 PUBMED: 25504635 PMCID: PMC4326541